Edgewell Personal Care Company (EPC) Stock Analysis
Edgewell is shedding low-quality assets, consolidating capacity and positioning for a structural margin re-rating from a deeply discounted consumer staples valuation.
Overview
Edgewell is in a decisive turnaround: near-term GAAP results are depressed by restructuring, divestiture accounting and plant transition costs, but underlying brands and adjusted profitability remain resilient. The Feminine Care sale sharply improves portfolio quality and balance-sheet flexibility, while core franchises retain defensible scale, IP and consumer loyalty. At roughly 11.25x normalized earnings and 0.51x sales, the stock trades at a steep staples discount despite improving margins, cash flow visibility and a June 2026 technical re-rating. The report assigns Outperform with a $26 12-month target.